Literature DB >> 27966292

Out-of-pocket medical costs and third-party healthcare costs for children with Down syndrome.

Andrew Kageleiry1, David Samuelson1, Mei Sheng Duh1, Patrick Lefebvre2, John Campbell3, Brian G Skotko4,5.   

Abstract

Prior analyses have estimated the lifetime total societal costs of a person with Down syndrome (DS); however, no studies capture the expected medical costs that patients with DS can expect to incur during childhood. The study utilized the OptumHealth Reporting and Insights administrative claims database from 1999 to 2013. Children with a diagnosis of DS were identified, and their time was divided into clinically relevant age categories. Patients with DS in each age category were matched to controls without chromosomal conditions. Out-of-pocket medical costs and third-party expenditures were compared between the patient-age cohorts with DS and matched controls. Patients with DS had significantly higher mean annual out-of-pocket costs than their matched controls within each age and cost category. Total annual incremental out-of-pocket costs associated with DS were highest among individuals from birth to age 1 ($1,907, P < 0.001). The main drivers of the incremental out-of-pocket costs associated with DS were inpatient costs in the 1st year of life ($925, P < 0.001) and outpatient costs in later years (ranging $183-$623, all P < 0.001). Overall, patients with DS incurred incremental out-of-pocket medical costs of $18,248 between birth and age 18 years; third-party payers incurred incremental costs of $230,043 during the same period. Across all age categories, mean total out-of-pocket annual costs were greater for individuals with DS than those of matched controls. On average, parents of children with DS pay an additional $84 per month for out-of-pocket medical expenses when costs are amortized over 18 years.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Down syndrome; children; out-of-pocket costs; third-party payers

Mesh:

Year:  2016        PMID: 27966292     DOI: 10.1002/ajmg.a.38050

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Out-of-pocket expenditures and care time for children with Down Syndrome: A single-hospital study in Mexico City.

Authors:  Silvia Martínez-Valverde; Guillermo Salinas-Escudero; Constanza García-Delgado; Juan Garduño-Espinosa; Verónica F Morán-Barroso; Víctor Granados-García; Ma Teresa Tiro-Sánchez; Filiberto Toledano-Toledano; Ma Vanessa Aldaz-Rodríguez
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

2.  A contingent model for cell-free DNA testing to detect fetal aneuploidy after first trimester combined screening.

Authors:  Carmen Cotarelo-Pérez; Raluca Oancea-Ionescu; Eloy Asenjo-de-la-Fuente; Dolores Ortega-de-Heredia; Patricia Soler-Ruiz; Pluvio Coronado-Martín; María Fenollar-Cortés
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-01-15

3.  Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis.

Authors:  Wei Zhang; Tima Mohammadi; Julie Sou; Aslam H Anis
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.240

4.  Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis.

Authors:  Chanane Wanapirak; Piyaluk Buddhawongsa; Woraluck Himakalasa; Auttapan Sarnwong; Theera Tongsong
Journal:  BMC Health Serv Res       Date:  2019-11-27       Impact factor: 2.655

5.  Effect of the Sharrard procedure on hip instability in children with Down syndrome: a retrospective study.

Authors:  Frederike E C M Mulder; Levinus A Bok; Florens Q M P van Douveren; Hans E H Pruijs; Adelgunde V C M Zeegers
Journal:  J Child Orthop       Date:  2021-10-01       Impact factor: 1.548

Review 6.  The Economic Costs of Childhood Disability: A Literature Review.

Authors:  Ahmed Ramadan Shokry Shahat; Giulia Greco
Journal:  Int J Environ Res Public Health       Date:  2021-03-29       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.